BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,826,000 | +18.5% | 303,642 | -0.5% | 0.07% | +15.5% |
| Q2 2022 | $3,229,000 | -41.4% | 305,157 | -10.0% | 0.06% | +13.7% |
| Q1 2022 | $5,512,000 | +16.8% | 339,009 | -0.5% | 0.05% | +88.9% |
| Q4 2021 | $4,720,000 | +4.7% | 340,779 | +8.6% | 0.03% | +17.4% |
| Q3 2021 | $4,509,000 | -9.0% | 313,806 | +0.1% | 0.02% | -4.2% |
| Q2 2021 | $4,955,000 | +130.5% | 313,393 | +48.2% | 0.02% | +100.0% |
| Q1 2021 | $2,150,000 | +5.7% | 211,407 | -64.3% | 0.01% | -7.7% |
| Q3 2020 | $2,034,000 | – | 592,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |